{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:13:39Z","timestamp":1785827619282,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["APQ-408675\/2018\\u20137"],"award-info":[{"award-number":["APQ-408675\/2018\\u20137"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["MR\/ R005850 \/1"],"award-info":[{"award-number":["MR\/ R005850 \/1"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.exppara.2020.108059","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T15:32:07Z","timestamp":1608132727000},"page":"108059","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis"],"prefix":"10.1016","volume":"221","author":[{"given":"Thiago A.R.","family":"Reis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o A.","family":"Oliveira-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora V.C.","family":"Mendon\u00e7a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaella R.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela P.","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda S.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana M.R.","family":"Antinarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory C.F.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-6981","authenticated-orcid":false,"given":"Maria V.","family":"Humbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Coimbra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2020.108059_bib1","doi-asserted-by":"crossref","first-page":"183473","DOI":"10.1016\/j.bbamem.2020.183473","article-title":"Membrane dynamics in Leishmania amazonensis and antileishmanial activities of \u03b2-carboline derivatives","volume":"1863","author":"Alonso","year":"2020","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.exppara.2020.108059_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.exppara.2020.108059_bib3","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5905","article-title":"A real-time PCR assay for quantification of parasite burden in murine models of leishmaniasis","volume":"6","author":"Antonia","year":"2018","journal-title":"Peer J"},{"key":"10.1016\/j.exppara.2020.108059_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"Bhattacharya","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.exppara.2020.108059_bib5","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.3390\/vaccines8020252","article-title":"Chimeric vaccines designed by immunoinformatics-activated polyfunctional and memory T cells that trigger protection against experimental visceral leishmaniasis","volume":"8","author":"Brito","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.exppara.2020.108059_bib6","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.exppara.2020.108059_bib7","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/AAC.00710-13","article-title":"In vitro synergistic effect of amphotericin B and allicin on Leishmania donovani and L. infantum. Antimicrob","volume":"58","author":"Corral","year":"2014","journal-title":"Agents Chemother"},{"key":"10.1016\/j.exppara.2020.108059_bib8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3389\/fimmu.2019.00670","article-title":"Cytokines: key determinants of resistance or disease progression in visceral leishmaniasis: opportunities for novel diagnostics and immunotherapy","volume":"10","author":"Dayakar","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exppara.2020.108059_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.parint.2016.07.005","article-title":"Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system","volume":"65","author":"Duarte","year":"2016","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2020.108059_bib10","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1007\/s11095-011-0586-3","article-title":"Mitochondria and Trypanosomatids: targets and drugs","volume":"28","author":"Fidalgo","year":"2011","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.exppara.2020.108059_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1515\/jtim-2015-0002","article-title":"Leishmaniasis revisited: current aspects on epidemiology, diagnosis and treatment","volume":"3","author":"Georgiadou","year":"2015","journal-title":"J. Transl. Int. Med."},{"key":"10.1016\/j.exppara.2020.108059_bib12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1128\/CMR.6.3.230","article-title":"Leishmaniases of the New World: current concepts and implications for future research","volume":"6","author":"Grimaldi","year":"1993","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.exppara.2020.108059_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.drudis.2013.08.005","article-title":"Novel therapeutic strategies for treatment of visceral leishmaniasis","volume":"18","author":"Jain","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.exppara.2020.108059_bib14","first-page":"435","article-title":"Lipid droplets and the management of cellular stress","volume":"92","author":"Jarc","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.exppara.2020.108059_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parint.2009.10.006","article-title":"Antileishmanial effect of cisplatin against murine visceral leishmaniasis","volume":"59","author":"Kaur","year":"2010","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.exppara.2020.108059_bib16","first-page":"1","article-title":"Immune responses during cutaneous and visceral leishmaniasis","volume":"30","author":"Kedzierski","year":"2014","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2020.108059_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/327167","article-title":"Mitochondrial dysfunction induces formation of lipid droplets as a generalized response to stress","author":"Lee","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.exppara.2020.108059_bib18","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1128\/AAC.00124-08","article-title":"Activity of hydroxyurea against Leishmania mexicana","volume":"52","author":"Martinez-Rojano","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.exppara.2020.108059_bib19","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0192-0561(00)00074-6","article-title":"Immunomodulators in infectious diseases: panoply of possibilites","volume":"22","author":"Masihi","year":"2000","journal-title":"Int. J. Immunopharm."},{"key":"10.1016\/j.exppara.2020.108059_bib20","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/ciy747","article-title":"Pharmacokinetics, safety, and efficacy of an allometric miltefosine regimen for the treatment of visceral leishmaniasis in Eastern African children: an open-label, phase II clinical trial","volume":"68","author":"Mbui","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2020.108059_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.exppara.2016.07.005","article-title":"Poloxamer 407 (Pluronic\u00aeF127)-based polymeric micelles for amphotericin B: in vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis","volume":"169","author":"Mendon\u00e7a","year":"2016","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2020.108059_bib22","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.exppara.2018.02.003","article-title":"Comparing the therapeutic efficacy of different amphotericin B-carrying delivery systems against visceral leishmaniasis","volume":"186","author":"Mendon\u00e7a","year":"2018","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2020.108059_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/614014","article-title":"The double-edged sword in pathogenic trypanosomatids: the pivotal role of mitochondria in oxidative stress and bioenergetics","volume":"2014","author":"Menna-Barreto","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.exppara.2020.108059_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41419-019-1370-2","article-title":"Cell death pathways in pathogenic Trypanosomatids: lessons of (over)kill","volume":"10","author":"Menna-Barreto","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.exppara.2020.108059_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.actatropica.2013.11.003","article-title":"Combination therapy with nitazoxanide and amphotericin B, Glucantime\u00ae, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes","volume":"130","author":"Mesquita","year":"2014","journal-title":"Acta Trop."},{"key":"10.1016\/j.exppara.2020.108059_bib26","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jac\/dkz049","article-title":"Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis","volume":"74","author":"Neira","year":"2019","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2020.108059_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.mbs.2017.11.009","article-title":"Application of optimal control to the onchocerciasis transmission model with treatment","volume":"297","author":"Omondi","year":"2018","journal-title":"Math. Biosci."},{"key":"10.1016\/j.exppara.2020.108059_bib28","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08982104.2017.1376682","article-title":"Liposomal formulations in the pharmacological treatment of leishmaniasis: a review","volume":"27","author":"Ortega","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.exppara.2020.108059_bib29","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.4269\/ajtmh.16-0242","article-title":"Pharmacovigilance of miltefosine in treatment of visceral leishmaniasis in endemic areas of Bihar, India","volume":"95","author":"Pandey","year":"2016","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2020.108059_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: implications for clinical use","volume":"9","author":"P\u00e9rez-Victoria","year":"2006","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.exppara.2020.108059_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007173","article-title":"The safety and efficacy of miltefosine in the long-term treatment of post-kala-azar dermal leishmaniasis in South Asia - a review and meta-analysis","volume":"13","author":"Pijpers","year":"2019","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2020.108059_bib32","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.exppara.2020.108059_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2174\/0929866526666190301114012","article-title":"Repurposing glyburide as antileishmanial agent to fight against leishmaniasis","volume":"26","author":"Rub","year":"2019","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.exppara.2020.108059_bib34","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1093\/jac\/dkq164","article-title":"CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis","volume":"65","author":"Sane","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.exppara.2020.108059_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1756-3305-3-107","article-title":"Targeting essential pathways in Trypanosomatids gives insights into protozoan mechanisms of cell death","volume":"3","author":"Smirlis","year":"2010","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.exppara.2020.108059_bib36","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exppara.2019.02.019","article-title":"Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis","volume":"199","author":"Soyer","year":"2019","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.exppara.2020.108059_bib37","first-page":"98","article-title":"Recent developments and future prospects in the treatment of visceral leishmaniasis","volume":"3","author":"Sundar","year":"2016","journal-title":"Ther. Adv. Infect. Dis"},{"key":"10.1016\/j.exppara.2020.108059_bib38","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1017\/S0031182017002116","article-title":"Chemotherapeutics of visceral leishmaniasis: present and future developments","volume":"145","author":"Sundar","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2020.108059_bib39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.4269\/ajtmh.19-0179","article-title":"Effectiveness of single-dose liposomal amphotericin B in visceral leishmaniasis in Bihar","volume":"101","author":"Sundar","year":"2019","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.exppara.2020.108059_bib40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/bcpt.12990","article-title":"Antileishmanial activity, cytotoxicity and mechanism of action of clioquinol against Leishmania infantum and Leishmania amazonensis species","volume":"123","author":"Tavares","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.exppara.2020.108059_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1051\/parasite\/2020027","article-title":"A clioquinol-containing Pluronic\u00ae F127 polymeric micelle system is effective in the treatment of visceral leishmaniasis in a murine model","volume":"27","author":"Tavares","year":"2020","journal-title":"Parasite"},{"key":"10.1016\/j.exppara.2020.108059_bib43","author":"World Health Organization"},{"key":"10.1016\/j.exppara.2020.108059_bib44","first-page":"68","article-title":"In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B","volume":"15","author":"Zauli-Nascimento","year":"2010","journal-title":"Trop. Med. Int. Health"},{"key":"10.1016\/j.exppara.2020.108059_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12889","article-title":"Leishmania parasitophorous vacuole membranes display phosphoinositides that create conditions for continuous Akt activation and a target for miltefosine in Leishmania infections","volume":"20","author":"Zhang","year":"2018","journal-title":"Cell Microbiol."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489420305841?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489420305841?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T02:35:46Z","timestamp":1777430146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489420305841"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":44,"alternative-id":["S0014489420305841"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2020.108059","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ivermectin presents effective and selective antileishmanial activity in vitro and in vivo against Leishmania infantum and is therapeutic against visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2020.108059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108059"}}